Based on recent data, Jazz Pharmaceuticals plc (JAZZ) shows an Average True Range (ATR) of 5.71 and an Enterprise Value of 11.34B. Its average trading volume over the past 3 months is 930.5K, indicating liquidity. These fundamental metrics provide insight into JAZZ's underlying financial health and market activity.
| ATR | 5.71 |
| Enterprise Value | 11.34B |
| Avg Vol (3 Months) | 930.5K |
| Avg Vol (10 Days) | 805.57K |
Jazz Pharmaceuticals plc (JAZZ) technical indicators as of July 10, 2026: the SMA 20 is 11.23%, SMA 50 at 11.87%, and SMA 200 at 36.99%. The RSI 14 value is 70.25, suggesting its current momentum. These technical analysis signals help assess JAZZ's price trends and potential future movements.
| SMA 20 | 11.23% |
| SMA 50 | 11.87% |
| SMA 200 | 36.99% |
| RSI 14 | 70.25 |
Jazz Pharmaceuticals plc (JAZZ) stock performance overview as of July 10, 2026: The 52-week high is $250.49 (currently -4.3% below), and the 52-week low is $105 (currently 97.9% above). Over the past year, JAZZ's performance is 36.91%, compared to the S&P 500's 5.16% change.
| 52-Week High | 250.49 |
| 52-Week High Chg | -4.30% |
| 52-Week Low | 105 |
| 52-Week Low Chg | +97.90% |
| S&P 500 52-Week Chg | 5.16% |
According to market data, Jazz Pharmaceuticals plc (JAZZ) stock's recent performance metrics show that over the last month, JAZZ is 1.8%, with a Year-to-Date (YTD) performance of -1.25%. Over the past year, the stock has seen a 36.91% change. These figures summarize JAZZ's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 250.49 | 250.49 | 250.49 | 250.49 | 250.49 | 250.49 |
| Low | 238.42 | 220.74 | 184.18 | 156.95 | 105 | 156.95 |
| Performance | +2.57% | +1.80% | +23.39% | +49.03% | +36.91% | -1.25% |
According to current financial data, JAZZ stock's P/E (TTM) ratio is 588.67, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for JAZZ, including P/S (3.42), P/B (3.30), and P/FCF (12.17), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | JAZZ | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 588.67 | -1.22 | -194.02 | 32.59 |
| P/S (TTM) | 3.42 | 3.68 | 466.98 | 5.98 |
| P/B (TTM) | 3.3 | 17.64 | 11.13 | 5.32 |
| P/FCF (TTM) | 12.17 | -16.39 | -599.65 | 30.1 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep